Litcius/Paper detail

Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019

Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Yu Akagi, Momoko Mawatari, Akihiro Ueda, Takehiro Izumo

2020Respiratory Investigation50 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineBiomarkerCoronavirus disease 2019 (COVID-19)Severity of illnessGastroenterologyReceiver operating characteristicDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Infectious disease (medical specialty)BiochemistryChemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019 | Litcius